Posts by Ignacio Inglessis-Azuaje, MD
-
Study Explores Novel Transcatheter Mitral Valve Replacement
The APOLLO Trial is investigating minimally invasive mitral valve replacement as an alternative to open heart surgery for patients with severe mitral valve regurgitation. Massachusetts General Hospital's team is leading efforts to explore the innovative procedure's safety and effectiveness.
-
TAVR Provides Benefits Over SAVR in Patients with Prior CABG
A comparative analysis of outcomes for patients undergoing aortic valve replacement show statistically significant benefits of transcatheter versus surgical modes.
-
First Minimally-invasive Transcatheter Mitral Valve Replacement in New England Performed at Mass General
Physicians at Massachusetts General Hospital recently became the first team in New England to perform a transcatheter mitral valve replacement in a non-calcified mitral valve.
Biography
Ignacio Inglessis, MD, is an Assistant Professor in Medicine at Harvard Medical School and Director of Adult Congenital Heart Disease Interventions at Massachusetts General Hospital. Dr. Inglessis is an active clinical consultant in all aspects of interventional cardiology, including transcatheter therapy for adult congenital, valvular and complex coronary heart disease.
Dr Inglessis has published more than 30 manuscripts and has co-authored 5 book chapters in the field of interventional cardiology for complex coronary and structural heart disease.
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.